Deoxyribozymes: cleaving a path to clinical trials
- 1 August 2004
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (8) , 395-397
- https://doi.org/10.1016/j.tips.2004.06.001
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolatesMolecular Therapy, 2003
- DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosisBiochemical and Biophysical Research Communications, 2003
- Cellular Uptake, Distribution, and Stability of 10-23 DeoxyribozymesAntisense and Nucleic Acid Drug Development, 2002
- DNAzymes to β1 and β3 mRNA Down-regulate Expression of the Targeted Integrins and Inhibit Endothelial Cell Capillary Tube Formation in Fibrin and MatrigelJournal of Biological Chemistry, 2002
- Vehicles for oligonucleotide delivery to tumoursJournal of Pharmacy and Pharmacology, 2002
- Catalytic Oligodeoxynucleotides Define a Key Regulatory Role for Early Growth Response Factor-1 in the Porcine Model of Coronary In-Stent RestenosisCirculation Research, 2001
- New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injuryNature Medicine, 1999
- Target site selection for an RNA-cleaving catalytic DNANature Biotechnology, 1999
- A general purpose RNA-cleaving DNA enzymeProceedings of the National Academy of Sciences, 1997
- Simple RNA enzymes with new and highly specific endoribonuclease activitiesNature, 1988